{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-046411","form_type":"8-K","ticker":"ALLR","cik":"0001860657","company_name":"Allarity Therapeutics, Inc.","filed_at":"2026-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.166728+00:00","generated_at":"2026-05-15T04:56:02.287800+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Allarity Therapeutics presents AACR posters on stenoparib for colorectal cancer and ovarian cancer survival","bullets":["Poster 2: stenoparib blocks WNT/β-catenin signaling and inhibits growth of colorectal cancer cell lines at clinically relevant concentrations.","Poster 1: Highest stenoparib DRP® scores are associated with enhanced overall survival in phase 2 ovarian cancer trial (NCT03878849).","CEO Thomas Jensen highlights stenoparib potential in colorectal cancer, a large area of unmet need in oncology.","DRP® companion diagnostic platform may identify patients most likely to achieve extended survival with stenoparib."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-046411","json":"https://secwatch.observer/filing/0001213900-26-046411.json","markdown":"https://secwatch.observer/filing/0001213900-26-046411.md","text":"https://secwatch.observer/filing/0001213900-26-046411.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026046411/0001213900-26-046411-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026046411/ea0287156-8k_allarity.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:56:02.287800+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}